HP said the Board expanded its size and elected Gianluca Pettiti as a director on February 21, 2025. He is Executive Vice President and President, Life Sciences, Diagnostics and Applied at Thermo Fisher Scientific Inc.

1. 01

   HP said the Board expanded its size and elected Gianluca Pettiti as a director on February 21, 2025. He is Executive Vice President and President, Life Sciences, Diagnostics and Applied at Thermo Fisher Scientific Inc.

2. 02

   The company said the Board determined that Pettiti is independent under the New York Stock Exchange listing standards and the company's Corporate Governance Guidelines. The same day, he was assigned to the Finance, Investment and Technology Committee and the HR and Compensation Committee.

3. 03

   HP said Pettiti will receive the same compensation generally paid to other non-employee directors, currently including an annual cash retainer of $105,000 and an annual equity retainer of $220,000 in fully vested shares. In his first partial year, both retainers will be pro-rated.

4. 04

   HP said the Board amended the Bylaws on February 21, 2025 to increase the number of authorized directorships from 14 to 15, in connection with Pettiti's appointment, and the amendment took effect the same day.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.